Search Within

April Chiu

Formats
  1. Journal Article (29)
  2. Meeting Abstract (27)
  3. Book Section (1)
Groups
  1. Department of Medicine (12)
  2. Department of Pathology and Laboratory Medicine (12)
  3. Center for Hematologic Malignancies (11)
  4. Hematologic Malignancies, Division of (11)
  5. Executive Committee, Center for Hematologic Malignancies (6)
  6. Lymphoma (6)

More Groups

People
  1. Ahmet Dogan (5)
  2. Denise Frosina (4)
  3. Achim Jungbluth (3)
  4. Ariela Noy (3)
  5. Barbara Spitzer (3)
  6. Efthymia Papalexi (3)

More People

Years
  1. 2020 (1)
  2. 2018 (2)
  3. 2017 (2)
  4. 2016 (11)
  5. 2015 (19)
  6. 2014 (9)

More Years

Publications
  1. Blood (14)
  2. Modern Pathology (9)
  3. Clinical Lymphoma, Myeloma and Leukemia (7)
  4. Laboratory Investigation (6)
  5. Oncotarget (5)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. Nature Research (9)
  3. Elsevier Inc. (8)
  4. Nature Publishing Group (8)
  5. Impact Journals (7)
  6. American Association for Cancer Research (3)

More Publishers

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: A report from The International DLBCL Rituximab-CHOP Consortium Program
    Journal Article

    Hu, S. M.; Xu-Monette, Z. Y.; Tzankov, A.; Green, T.; Wu, L.; Balasubramanyam, A.; Liu, W. M.; Visco, C.; Li, Y.; Miranda, R. N.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Detection of an NRAS mutation in Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Abdel-Wahab, O.; Pentsova, E.; Borsu, L.; Chiu, A.; Teruya-Feldstein, J.; Hyman, D. M.; Rosenblum, M.
    Blood (2013)

    Fulltext@MSK | Save
  • Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: A report from an international DLBCL rituximab-CHOP consortium program study
    Journal Article

    Visco, C.; Tzankov, A.; Xu-Monette, Z. Y.; Miranda, R. N.; Tai, Y. C.; Li, Y.; Liu, W. M.; d'Amore, E. S. G.; Montes-Moreno, S.; Dybkær, K.; more...
    Haematologica (2013)

    Fulltext@MSK | Save
  • Subtypes of systemic mastocytosis exhibit distinct immunomorphologic features in bone marrow biopsies
    Meeting Abstract

    Chiu, A.; Czader, M. B.; Ochs, R. C.; Wang, D.; Park, D. C.; Achim, J. A.; Frosina, D.; Goswami, A.; Julie, T. F.; Orazi, A.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Subtypes of systemic mastocytosis exhibit distinct immunomorphologic features in bone marrow biopsies
    Meeting Abstract

    Chiu, A.; Czader, M. B.; Ochs, R. C.; Wang, D.; Park, D. C.; Achim, J. A.; Frosina, D.; Goswami, A.; Julie, T. F.; Orazi, A.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-cell leukemia/lymphoma presenting outside of Japan
    Meeting Abstract

    Lunning, M. A.; Chiu, A.; Feldstein, J. T.; Maragulia, J. C.; Moskowitz, A.; Matasar, M. J.; Straus, D. J.; Noy, A.; Myskowski, P. L.; Zelenetz, A. D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: Report from an International DLBCL Rituximab-CHOP Consortium Program Study
    Journal Article

    Xu-Monette, Z. Y.; Wu, L.; Visco, C.; Tai, Y. C.; Tzankov, A.; Liu, W. M.; Montes-Moreno, S.; Dybkær, K.; Chiu, A.; Orazi, A.; more...
    Blood (2012)

    Fulltext@MSK | Save